English

GENOCEA BIOSCIENCES, INC.

EDGAR

GNCA Quarterly report (10-Q) · filed 2022-05-05

76 filing records in this dataset, filed from 2013-12-23 to 2022-05-05. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

308 thousand Unit12

2014 Q4 · Unit12

Exact inputs and evidence

Revenue: 308000 Unit12 Source

Operating margin

-3,547.4%

2014 Q4 · %

Exact inputs and evidence

Operating Income: -33166000 Unit12 Source
Operating Income: -22240000 Unit12 Source
Revenue: 308000 Unit12 Source

Operating cash flow

-8.41 million Unit12

2014 Q4 · Unit12

Exact inputs and evidence

Operating Cash Flow: -27604000 Unit12 Source
Operating Cash Flow: -19192000 Unit12 Source

Free cash flow

-8.7 million Unit12

2014 Q4 · Unit12

Exact inputs and evidence

Operating Cash Flow: -27604000 Unit12 Source
Operating Cash Flow: -19192000 Unit12 Source
Capital Expenditure: 1520000 Unit12 Source
Capital Expenditure: 1237000 Unit12 Source

Cash and cash equivalents: 20.1 million USD 2022-03-31 Source
Exact value

20100000 USD
Long-term debt including current maturities: 7.6 million USD 2022-03-31 Source
Exact value

7600000 USD
Shares outstanding: 58.7 million shares 2022-03-31 Source
Exact value

58733759 shares

Reported share-count change

8.03% · 4.37 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

54368582 shares · 2021-03-31· Source
58733759 shares · 2022-03-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-05-05.

Financial data available through: 2021-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2021-12-31
Net income: 9 of 11 periods available· newest 2021-12-31
Operating cash flow: 9 of 11 periods available· newest 2021-12-31
Capital expenditure: 9 of 11 periods available· newest 2021-12-31
Total assets: 9 of 11 periods available· newest 2021-12-31
Total liabilities: 9 of 11 periods available· newest 2021-12-31
Current assets: 9 of 11 periods available· newest 2021-12-31
Current liabilities: 9 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2021-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2021-12-31
Shares outstanding: 9 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 10.52 million

Prior period

−USD 43.71 million

2020-01-01 – 2020-12-31
Current period

−USD 33.2 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-33196000 − -43714000 = 10518000 USD

-43714000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-33196000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GENOCEA BIOSCIENCES, INC. · 2021-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Year-over-year change in Net income: 10518000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -33196000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#1450989 Filing: 000145761222000039 Input fundies:NetIncome: -43714000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#1452165 Filing: 000145761222000039
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 3.75 million

Prior period

−USD 41.65 million

2020-01-01 – 2020-12-31
Current period

−USD 45.4 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-45400000 − -41651000 = -3749000 USD

-41651000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-45400000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GENOCEA BIOSCIENCES, INC. · 2021-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Year-over-year change in Operating cash flow: -3749000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -45400000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#999439 Filing: 000145761222000039 Input fundies:OperatingCashFlow: -41651000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#943839 Filing: 000145761222000039
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+27.2%

Prior period

USD 2.59 million

2020-01-01 – 2020-12-31
Current period

USD 3.29 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

3288000 − 2585000 = 703000 USD

2585000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
3288000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GENOCEA BIOSCIENCES, INC. · 2021-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Year-over-year change in Capital expenditure: 703000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3288000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#945589 Filing: 000145761222000039 Input fundies:CapitalExpenditure: 2585000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#946578 Filing: 000145761222000039
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	−USD 20.81 million Exact value Exact value: -20806000 USD 2013-01-01 – 2013-12-31: -20806000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOCEA BIOSCIENCES, INC. · 2013-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Net Income: -20806000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20806000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761216000048/gnca-20151231.xml#293736 Filing: 000145761216000048 The citation records this snapshot. The page link may show a newer release later.	−USD 19.87 million Exact value Exact value: -19873000 USD 2013-01-01 – 2013-12-31: -19873000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOCEA BIOSCIENCES, INC. · 2013-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Operating Cash Flow: -19873000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19873000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761216000048/gnca-20151231.xml#292980 Filing: 000145761216000048 The citation records this snapshot. The page link may show a newer release later.	USD 389,000 Exact value Exact value: 389000 USD 2013-01-01 – 2013-12-31: 389000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOCEA BIOSCIENCES, INC. · 2013-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Capital Expenditure: 389000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 389000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761216000048/gnca-20151231.xml#306733 Filing: 000145761216000048 The citation records this snapshot. The page link may show a newer release later.	−USD 20.26 million Calculation and evidence -19873000 − 389000 USD Exact free cash flow: -20262000 USD 2013-01-01 – 2013-12-31: -19873000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 389000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOCEA BIOSCIENCES, INC. · 2013-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Free cash flow: -20262000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19873000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761216000048/gnca-20151231.xml#292980 Filing: 000145761216000048 Input fundies:CapitalExpenditure: 389000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761216000048/gnca-20151231.xml#306733 Filing: 000145761216000048 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 35.3 million Exact value Exact value: -35296000 USD 2014-01-01 – 2014-12-31: -35296000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOCEA BIOSCIENCES, INC. · 2014-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Net Income: -35296000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35296000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761217000009/gnca-20161231.xml#285239 Filing: 000145761217000009 The citation records this snapshot. The page link may show a newer release later.	−USD 27.6 million Exact value Exact value: -27604000 USD 2014-01-01 – 2014-12-31: -27604000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOCEA BIOSCIENCES, INC. · 2014-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Operating Cash Flow: -27604000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27604000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761217000009/gnca-20161231.xml#284483 Filing: 000145761217000009 The citation records this snapshot. The page link may show a newer release later.	USD 1.52 million Exact value Exact value: 1520000 USD 2014-01-01 – 2014-12-31: 1520000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOCEA BIOSCIENCES, INC. · 2014-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Capital Expenditure: 1520000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1520000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761217000009/gnca-20161231.xml#297904 Filing: 000145761217000009 The citation records this snapshot. The page link may show a newer release later.	−USD 29.12 million Calculation and evidence -27604000 − 1520000 USD Exact free cash flow: -29124000 USD 2014-01-01 – 2014-12-31: -27604000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 1520000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOCEA BIOSCIENCES, INC. · 2014-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Free cash flow: -29124000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27604000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761217000009/gnca-20161231.xml#284483 Filing: 000145761217000009 Input fundies:CapitalExpenditure: 1520000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761217000009/gnca-20161231.xml#297904 Filing: 000145761217000009 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 42.48 million Exact value Exact value: -42483000 USD 2015-01-01 – 2015-12-31: -42483000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOCEA BIOSCIENCES, INC. · 2015-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Net Income: -42483000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42483000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#238113 Filing: 000145761218000019 The citation records this snapshot. The page link may show a newer release later.	−USD 38.36 million Exact value Exact value: -38360000 USD 2015-01-01 – 2015-12-31: -38360000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOCEA BIOSCIENCES, INC. · 2015-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Operating Cash Flow: -38360000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38360000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#237357 Filing: 000145761218000019 The citation records this snapshot. The page link may show a newer release later.	USD 2.78 million Exact value Exact value: 2784000 USD 2015-01-01 – 2015-12-31: 2784000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOCEA BIOSCIENCES, INC. · 2015-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Capital Expenditure: 2784000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2784000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#251322 Filing: 000145761218000019 The citation records this snapshot. The page link may show a newer release later.	−USD 41.14 million Calculation and evidence -38360000 − 2784000 USD Exact free cash flow: -41144000 USD 2015-01-01 – 2015-12-31: -38360000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 2784000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOCEA BIOSCIENCES, INC. · 2015-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Free cash flow: -41144000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38360000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#237357 Filing: 000145761218000019 Input fundies:CapitalExpenditure: 2784000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#251322 Filing: 000145761218000019 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 49.57 million Exact value Exact value: -49573000 USD 2016-01-01 – 2016-12-31: -49573000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOCEA BIOSCIENCES, INC. · 2016-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Net Income: -49573000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -49573000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#239105 Filing: 000145761218000019 The citation records this snapshot. The page link may show a newer release later.	−USD 41.84 million Exact value Exact value: -41835000 USD 2016-01-01 – 2016-12-31: -41835000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOCEA BIOSCIENCES, INC. · 2016-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Operating Cash Flow: -41835000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41835000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#237609 Filing: 000145761218000019 The citation records this snapshot. The page link may show a newer release later.	USD 2.54 million Exact value Exact value: 2538000 USD 2016-01-01 – 2016-12-31: 2538000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOCEA BIOSCIENCES, INC. · 2016-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Capital Expenditure: 2538000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2538000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#251532 Filing: 000145761218000019 The citation records this snapshot. The page link may show a newer release later.	−USD 44.37 million Calculation and evidence -41835000 − 2538000 USD Exact free cash flow: -44373000 USD 2016-01-01 – 2016-12-31: -41835000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 2538000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOCEA BIOSCIENCES, INC. · 2016-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Free cash flow: -44373000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41835000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#237609 Filing: 000145761218000019 Input fundies:CapitalExpenditure: 2538000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/gnca-20171231.xml#251532 Filing: 000145761218000019 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 56.71 million Exact value Exact value: -56710000 USD 2017-01-01 – 2017-12-31: -56710000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOCEA BIOSCIENCES, INC. · 2017-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Net Income: -56710000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -56710000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761219000027/gnca-20181231.xml#203543 Filing: 000145761219000027 The citation records this snapshot. The page link may show a newer release later.	−USD 47.6 million Exact value Exact value: -47599000 USD 2017-01-01 – 2017-12-31: -47599000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOCEA BIOSCIENCES, INC. · 2017-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Operating Cash Flow: -47599000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47599000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761219000027/gnca-20181231.xml#202423 Filing: 000145761219000027 The citation records this snapshot. The page link may show a newer release later.	USD 1.18 million Exact value Exact value: 1178000 USD 2017-01-01 – 2017-12-31: 1178000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOCEA BIOSCIENCES, INC. · 2017-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Capital Expenditure: 1178000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1178000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761219000027/gnca-20181231.xml#215756 Filing: 000145761219000027 The citation records this snapshot. The page link may show a newer release later.	−USD 48.78 million Calculation and evidence -47599000 − 1178000 USD Exact free cash flow: -48777000 USD 2017-01-01 – 2017-12-31: -47599000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1178000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOCEA BIOSCIENCES, INC. · 2017-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Free cash flow: -48777000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47599000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761219000027/gnca-20181231.xml#202423 Filing: 000145761219000027 Input fundies:CapitalExpenditure: 1178000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761219000027/gnca-20181231.xml#215756 Filing: 000145761219000027 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 27.81 million Exact value Exact value: -27811000 USD 2018-01-01 – 2018-12-31: -27811000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOCEA BIOSCIENCES, INC. · 2018-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Net Income: -27811000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27811000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761220000015/gnca-20191231.xml#192845 Filing: 000145761220000015 The citation records this snapshot. The page link may show a newer release later.	−USD 41.24 million Exact value Exact value: -41235000 USD 2018-01-01 – 2018-12-31: -41235000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOCEA BIOSCIENCES, INC. · 2018-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Operating Cash Flow: -41235000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41235000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761220000015/gnca-20191231.xml#191810 Filing: 000145761220000015 The citation records this snapshot. The page link may show a newer release later.	USD 241,000 Exact value Exact value: 241000 USD 2018-01-01 – 2018-12-31: 241000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOCEA BIOSCIENCES, INC. · 2018-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Capital Expenditure: 241000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 241000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761220000015/gnca-20191231.xml#202280 Filing: 000145761220000015 The citation records this snapshot. The page link may show a newer release later.	−USD 41.48 million Calculation and evidence -41235000 − 241000 USD Exact free cash flow: -41476000 USD 2018-01-01 – 2018-12-31: -41235000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 241000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOCEA BIOSCIENCES, INC. · 2018-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Free cash flow: -41476000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41235000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761220000015/gnca-20191231.xml#191810 Filing: 000145761220000015 Input fundies:CapitalExpenditure: 241000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761220000015/gnca-20191231.xml#202280 Filing: 000145761220000015 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 38.95 million Exact value Exact value: -38950000 USD 2019-01-01 – 2019-12-31: -38950000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOCEA BIOSCIENCES, INC. · 2019-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Net Income: -38950000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38950000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761221000022/gnca-20201231.htm#1427209 Filing: 000145761221000022 The citation records this snapshot. The page link may show a newer release later.	−USD 37.73 million Exact value Exact value: -37734000 USD 2019-01-01 – 2019-12-31: -37734000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOCEA BIOSCIENCES, INC. · 2019-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Operating Cash Flow: -37734000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37734000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761221000022/gnca-20201231.htm#930441 Filing: 000145761221000022 The citation records this snapshot. The page link may show a newer release later.	USD 1.14 million Exact value Exact value: 1135000 USD 2019-01-01 – 2019-12-31: 1135000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOCEA BIOSCIENCES, INC. · 2019-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Capital Expenditure: 1135000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1135000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761221000022/gnca-20201231.htm#933166 Filing: 000145761221000022 The citation records this snapshot. The page link may show a newer release later.	−USD 38.87 million Calculation and evidence -37734000 − 1135000 USD Exact free cash flow: -38869000 USD 2019-01-01 – 2019-12-31: -37734000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1135000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOCEA BIOSCIENCES, INC. · 2019-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Free cash flow: -38869000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37734000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761221000022/gnca-20201231.htm#930441 Filing: 000145761221000022 Input fundies:CapitalExpenditure: 1135000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761221000022/gnca-20201231.htm#933166 Filing: 000145761221000022 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 43.71 million Exact value Exact value: -43714000 USD 2020-01-01 – 2020-12-31: -43714000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOCEA BIOSCIENCES, INC. · 2020-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Net Income: -43714000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43714000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#1452165 Filing: 000145761222000039 The citation records this snapshot. The page link may show a newer release later.	−USD 41.65 million Exact value Exact value: -41651000 USD 2020-01-01 – 2020-12-31: -41651000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOCEA BIOSCIENCES, INC. · 2020-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Operating Cash Flow: -41651000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41651000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#943839 Filing: 000145761222000039 The citation records this snapshot. The page link may show a newer release later.	USD 2.59 million Exact value Exact value: 2585000 USD 2020-01-01 – 2020-12-31: 2585000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOCEA BIOSCIENCES, INC. · 2020-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Capital Expenditure: 2585000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2585000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#946578 Filing: 000145761222000039 The citation records this snapshot. The page link may show a newer release later.	−USD 44.24 million Calculation and evidence -41651000 − 2585000 USD Exact free cash flow: -44236000 USD 2020-01-01 – 2020-12-31: -41651000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 2585000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOCEA BIOSCIENCES, INC. · 2020-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Free cash flow: -44236000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41651000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#943839 Filing: 000145761222000039 Input fundies:CapitalExpenditure: 2585000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#946578 Filing: 000145761222000039 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 33.2 million Exact value Exact value: -33196000 USD 2021-01-01 – 2021-12-31: -33196000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOCEA BIOSCIENCES, INC. · 2021-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Net Income: -33196000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33196000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#1450989 Filing: 000145761222000039 The citation records this snapshot. The page link may show a newer release later.	−USD 45.4 million Exact value Exact value: -45400000 USD 2021-01-01 – 2021-12-31: -45400000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOCEA BIOSCIENCES, INC. · 2021-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Operating Cash Flow: -45400000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45400000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#999439 Filing: 000145761222000039 The citation records this snapshot. The page link may show a newer release later.	USD 3.29 million Exact value Exact value: 3288000 USD 2021-01-01 – 2021-12-31: 3288000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOCEA BIOSCIENCES, INC. · 2021-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Capital Expenditure: 3288000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3288000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#945589 Filing: 000145761222000039 The citation records this snapshot. The page link may show a newer release later.	−USD 48.69 million Calculation and evidence -45400000 − 3288000 USD Exact free cash flow: -48688000 USD 2021-01-01 – 2021-12-31: -45400000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3288000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOCEA BIOSCIENCES, INC. · 2021-12-31 GENOCEA BIOSCIENCES, INC. (edgar:1457612) Free cash flow: -48688000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1457612?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45400000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#999439 Filing: 000145761222000039 Input fundies:CapitalExpenditure: 3288000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1457612/000145761222000039/gnca-20211231.htm#945589 Filing: 000145761222000039 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

76 filings · 2,003 latest values · 2,003 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001457612, 1457612, GNCA, edgar:1457612

Also known as GENOCEA BIOSCIENCES INC, GENOCEA BIOSCIENCES, INC., Genocea Biosciences, Inc.

GENOCEA BIOSCIENCES, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation